Structural Formula (Vor01 0003 01 V3)
Voriconazole Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-027
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 71288-027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Meitheal Logo (Vor01 0003 02 V3)
Iprincipal Display Panel – Voriconazole For Injection, 200 mg Container Label (Vor01 0003 03 V3)
This appears to be the label of a medication called Voriconazole. It is in a single-dose vial form and is for intravenous infusion only. The vial contains 200 mg of Voriconazole medication that needs to be discarded if unused. The rest of the text contains various codes and numbers and is not very useful.*
Principal Display Panel – Voriconazole For Injection, 200 mg Carton (Vor01 0003 04 V3)
Voriconazole for Injection is used for Intravenous Infusion only. Each mL after reconstitution contains 10 mg of voriconazole and 160 mg sulfobutyl ether beta-cyclodextrin sodium (SBECD). The solution must be diluted further before use. Dosage and usage information are included. The drug must be stored at a temperature between 15° to 30°C (59° to 86°F) according to USP Controlled Room Temperature guidelines. The container closure is not made with natural rubber latex. The manufacturer is Meitheal Pharmaceuticals based in Chicago with a subsidiary in Nanjing, China. The product is sold in single-dose vials, and unused portions should be discarded.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
